Skip to main content

Table 1 The four gene panels designed and adopted in this study

From: Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management

  Genes Number of amplicons Cumulative target (bps) Number of samples
Parkinson panel GBA, ATP13A2, PARK7, PINK1, EIF4G1, UCHL1, SNCA, PARK2, LRRK2, VPS35 368 76,146 54
COL4 panel COL4A1, COL4A2 157 31,842 23
CACNA1A panel CACNA1A 83 16,837 27
ATP1A2 panel ATP1A2 57 10,244 15
  1. For each panel, the genes involved are reported, together with the total number of amplicons per panel and the dimension of the target regions in base pairs. For each panel, the number of sequenced samples is reported